Xperi Inc.
XPER
$7.77
-$0.27-3.36%
Weiss Ratings | XPER - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | XPER - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | XPER - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.11 | |||
Price History | XPER - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -4.19% | |||
30-Day Total Return | -14.05% | |||
60-Day Total Return | -25.50% | |||
90-Day Total Return | -16.63% | |||
Year to Date Total Return | -25.65% | |||
1-Year Total Return | -30.00% | |||
2-Year Total Return | -26.14% | |||
3-Year Total Return | -- | |||
5-Year Total Return | -- | |||
52-Week High % Change | -33.69% | |||
52-Week Low % Change | 16.69% | |||
Price | XPER - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $12.13 | |||
52-Week Low Price | $6.89 | |||
52-Week Low Price (Date) | Aug 05, 2024 | |||
52-Week High Price (Date) | Mar 28, 2024 | |||
Valuation | XPER - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 356.89M | |||
Enterprise Value | 311.61M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.32 | |||
Earnings Per Share Growth | -90.07% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.74 | |||
Price/Book (Q) | 0.83 | |||
Enterprise Value/Revenue (TTM) | 0.63 | |||
Price | $7.77 | |||
Enterprise Value/EBITDA (TTM) | -10.55 | |||
Enterprise Value/EBIT | -3.64 | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | XPER - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 45.52M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | XPER - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 408 519 9100 | |||
Address | 2190 Gold Street San Jose, CA 95002 | |||
Website | xperi.com | |||
Country | United States | |||
Year Founded | 2019 | |||
Profitability | XPER - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -17.32% | |||
Profit Margin | -2.83% | |||
Management Effectiveness | XPER - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -7.97% | |||
Return on Equity | -- | |||
Income Statement | XPER - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 493.69M | |||
Total Revenue (TTM) | 493.69M | |||
Revenue Per Share | $10.85 | |||
Gross Profit (TTM) | 379.93M | |||
EBITDA (TTM) | -29.53M | |||
EBIT (TTM) | -85.54M | |||
Net Income (TTM) | -14.01M | |||
Net Income Avl. to Common (TTM) | -14.01M | |||
Total Revenue Growth (Q YOY) | -10.84% | |||
Earnings Growth (Q YOY) | 348.74% | |||
EPS Diluted (TTM) | -0.32 | |||
EPS Diluted Growth (Q YOY) | 279.02% | |||
Balance Sheet | XPER - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 130.56M | |||
Cash Per Share (Q) | $2.87 | |||
Total Current Assets (Q) | 304.87M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 429.08M | |||
Current Ratio (Q) | 1.645 | |||
Book Value Per Share (Q) | $9.68 | |||
Total Assets (Q) | 667.76M | |||
Total Current Liabilities (Q) | 185.35M | |||
Total Debt (Q) | 85.29M | |||
Total Liabilities (Q) | 238.68M | |||
Total Common Equity (Q) | 429.08M | |||
Cash Flow | XPER - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 50.82M | |||
Cash from Financing (TTM) | -19.35M | |||
Net Change in Cash (TTM) | -23.87M | |||
Levered Free Cash Flow (TTM) | 12.00M | |||
Cash from Operations (TTM) | -55.34M | |||